Tazmeen Fadra-Khan

Tazmeen Fadra-Khan is a highly experienced Senior Research Scientist at Curia, with a robust background in drug discovery and development. Since April 2017, Tazmeen has been involved in comprehensive screening of new molecular entities (NMEs) and hit qualification processes. Prior to Curia, Tazmeen held various roles at Boehringer Ingelheim from 2002 to 2017, progressing from Scientist I to Scientist III, focusing on cell-based, biochemical, and radioactive assays to support lead optimization. Tazmeen began a career in laboratory technology at P. D. Hinduja National Hospital and holds a Master of Arts in Microbiology from the University at Buffalo, along with degrees from the University of Mumbai, including a Bachelor of Science in Microbiology and a Diploma in Clinical Analysis.